Cholinesterase inhibitors exert a protective effect on endothelial damage in Alzheimer disease patients

Journal of the Neurological Sciences

Volumn 229-230, Issue , 2005, Pages 211-213

  Borroni, Barbara ^a   Agosti, Chiara ^a   Martini, Giuliana ^a   Volpi, Roberta ^a   Brambilla, Cristina ^a   Caimi, Luigi ^a   Di Luca, Monica ^b   Padovani, Alessandro ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer disease; Amyloid precursor protein; Cholinesterase inhibitors

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINESTERASE INHIBITOR; DONEPEZIL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; THROMBOMODULIN;

ADULT; AGED; ALZHEIMER DISEASE; BLOOD CLOTTING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM INJURY; FEMALE; FIBRINOLYSIS; HUMAN; MALE; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; PATIENT SELECTION; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC DISEASE;

EID: 14844301636     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.11.030     Document Type: Conference Paper

References (13)

1. E. Giacobini Cholinestarese inhibitors: from the Calebar bean to Alzheimer therapy E. Giacobini Cholinesterase and cholinesterase inhibitors 2000 Martin Dunitz London 181 226
2. M. Racchi, and S. Govoni Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism Trends Pharmacol. Sci. 20 1999 418 423
3. S. Rossner, U. Ueberham, J. Yu, L. Kirazov, R. Schliebs, and J.R. Perez-Polo In vivo regulation of amyloid precursor protein secretion in rat neocortex by cholinergic activity Eur. J. Neurosci. 9 10 1997 2125 2134
4. A. Padovani, L. Pastorino, and B. Borroni Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD Neurology 57 2001 2243 2248
5. B. Borroni, F. Colciaghi, and L. Pastorino Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment Arch. Neurol. 58 2001 442 446
6. B. Borroni, F. Colciaghi, and L. Pastorino ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model Eur. Neuropsychopharmacol. 12 2002 195 200
7. J.E. Gardella, J. Ghiso, G.A. Gorgone, D. Marratta, A.P. Kaplan, and B. Frangione Intact Alzheimer amyloid precursor protein (APP) is present in platelet membrane and is encoded by platelet mRNA Biochem. Biophys. Res. Commun. 173 1990 1292 1298
8. F. Colciaghi, E. Marcello, B. Borroni, M. Zimmermann, C. Caltagirone, and F. Cattabeni Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease Neurology 62 3 2004 498 501
9. D. Mari, L. Parnetti, R. Coppola, B. Bottasso, G.P. Reboldi, and U. Senin Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease Thromb. Haemost. 75 2 1996 216 218
10. B. Borroni, R. Volpi, G. Martini, R. Del Bono, S. Archetti, and F. Colciaghi Peripheral blood abnormalities in Alzheimer disease: evidence for early endothelial dysfunction Alzheimer Dis. Assoc. Disord. 16 3 2002 150 155
11. R.N. Kalaria, and P. Hedera β-Amyloid vasoactivity in Alzheimer's disease Lancet 347 1996 1492 1493
12. T. Thomas, G. Thomas, C. McLendon, T. Sutton, and M. Mullan Beta amyloid mediated vasoactivity and vascular endothelial damage Nature 380 6570 1996 168 171
13. F. Crawford, Z. Suo, and C. Fang Charaterization of the in vitro vasoactivity of Abeta peptide Exp. Neurol. 150 1998 159 168